Spero Therapeutics, Inc. (SPRO) SEC Filings — 2024
18 SEC filings for Spero Therapeutics, Inc. (SPRO) in 2024.
Filings
- Spero Therapeutics Files 8-K on Financials — 8-K · Nov 14, 2024
- Spero Therapeutics Files Q3 2024 10-Q — 10-Q · Nov 14, 2024
- Spero Therapeutics Files 8-K — 8-K · Oct 29, 2024
- Merck Acquires Spero Therapeutics for $277M — 8-K · Sep 10, 2024
- Spero Therapeutics Files 8-K — 8-K · Aug 5, 2024
- Spero Therapeutics Files Q2 2024 10-Q — 10-Q · Aug 5, 2024
- Spero Therapeutics Announces Director Changes and Shareholder Votes — 8-K · Jun 3, 2024
- Spero Therapeutics Files 8-K on Financials — 8-K · May 15, 2024
- Spero Therapeutics Files 10-Q for Period Ending March 31, 2024 — 10-Q · May 15, 2024
- Spero Therapeutics, Inc. files DEF 14A for annual meeting. — DEF 14A · Apr 16, 2024
- Merck Acquires Spero Therapeutics for $1.1 Billion — 8-K · Mar 29, 2024
- Spero Therapeutics Files 8-K on Financials — 8-K · Mar 13, 2024
- Spero Therapeutics, Inc. Files 2023 Annual Report on Form 10-K — 10-K · Mar 13, 2024
- Spero Therapeutics, Inc. SC 13G Filing — SC 13G · Feb 14, 2024
- SPRO 8-K: Executive/Director Changes, Compensation Arrangements — 8-K · Feb 9, 2024
- Spero Therapeutics Files 8-K on Jan 8, Signals New Material Info — 8-K · Jan 8, 2024
- Spero Therapeutics Files Routine 8-K, Confirms Nasdaq Listing — 8-K · Jan 5, 2024
- Spero Therapeutics Files Routine 8-K on Jan 2, 2024 — 8-K · Jan 2, 2024